Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ lead programs target the treatment of Rett syndrome and spinal muscular atrophy with respiratory distress type 1 (SMARD1). 

Biotechnology

Alcyone Therapeutics

Alcyone Therapeutics' headquarters in Lowell, MA, United States

Pj Anand

Andrew East

Ravi Mehrotra

Nicolas Wein

Maurizio Pellechia

Sanchita Bhatnagar

Isabelle Aubert

Laura Ferraiuolo

Dave Arnold

Timothy Benke

Edgar D. Jannotta, Jr.

Dennis Durbin

Cameron Durrant

Richard Upton

Piratip Pratumsuwan

David Donabedian

Jeffrey L. Neul

Roxana O Carare

The Clinical and Regulatory Affairs team at Alcyone Therapeutics plays a critical role in overseeing the development and implementation of clinical trials for their innovative CNS therapies. This team ensures compliance with regulatory requirements, facilitates communication with health authorities, and provides scientific guidance throughout the clinical development process. By integrating clinical insights and regulatory expertise, they help drive the advancement of Alcyone’s gene therapy programs targeting severe neurological conditions.

Clinical and Regulatory Affairs

The Leadership Team at Alcyone Therapeutics is responsible for driving strategic direction and operational execution across the organization. Comprised of top executives in product development, research, program management, and business strategy, this team collaborates to advance innovative AAV gene therapy programs, ensuring alignment with the company's mission to enhance treatment options for severe CNS conditions. Their collective expertise guides decision-making processes, resource allocation, and the pursuit of partnerships that support the company's growth and success in the biotechnology landscape.

Leadership Team

The Research and Development team at Alcyone Therapeutics focuses on innovating and advancing gene therapy solutions for severe neurological conditions. This team, composed of scientists and engineers, collaborates to develop and optimize the company's proprietary CNS delivery technology, conduct preclinical research, and advance clinical programs targeting Rett syndrome and SMARD1. Their efforts are critical in transforming scientific breakthroughs into effective therapies that enhance patient outcomes in the central nervous system.

Research and Development

The Program and Project Management team at Alcyone Therapeutics plays a critical role in overseeing the strategic planning, execution, and coordination of the company's pipeline programs. This team collaborates across disciplines to ensure the efficient development of AAV gene therapies, aligning resources and timelines while managing project risk to drive innovations in treating severe neurological conditions. Their oversight encompasses everything from quality assurance to strategic alliances, enabling the successful advancement of life-changing therapies for patients.

Program and Project Management

The Finance and Administration team at Alcyone Therapeutics is responsible for managing the company's financial strategy, budgeting, and accounting practices, ensuring effective allocation of resources to support the development of innovative CNS therapies. This team also oversees administrative operations, providing crucial support for organizational efficiency and compliance, thereby enabling the company to focus on advancing its gene therapy programs for neurological conditions.

Alcyone Therapeutics

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Program and Project Management

Finance and Administration

Offices

Alcyone Therapeutics

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Program and Project Management

Finance and Administration

Offices

Related companies